Hello Heart raises $70 million
Hello Heart, a digital therapeutics company focusing exclusively on heart disease, has raised $70 million in Series D financing to support “significant growth in customer demand.” Growth equity firm Stripes led the round.
Founded in 2013, the Israeli startup’s flagship solution is an FDA-cleared blood pressure monitor coupled with an app that allows people to track their blood pressure, pulse, medications, weight, and activity using AI-based technology. The app provides real-time alerts to extremely high readings and encourages users to reach out to their physicians and healthcare professionals to catch risk in time.
Looking ahead, Hello Heart intends to deepen the use cases of their artificial intelligence engines to help manage heart health, which will include enhancing lifestyle digital coaching modules, and adding whole heart health functionality such as deeper medication tracking capabilities, cholesterol tracking and hyperlipidemia digital coaching.
“Hypertension affects 47% of Americans, and heart health in some way touches all of us. Everyone has a family member or colleague that is affected by heart disease. We empower people to understand, manage, and self-improve their heart health using the app technology and behavioral science. We make it easy for employers to work with Hello Heart, and it just works. We are thrilled to be working with so many of the nation’s leading employers as they empower their employees to make smart and healthy choices.” – Maayan Cohen, co-founder and CEO of Hello Heart.
“Hypertension and other cardiac diseases are the most pervasive chronic conditions and largest cost drivers in the U.S. healthcare system. Hello Heart stands out as the only dedicated, fully digital program with an incredible patient experience that drives exceptional results. Our investment extends our longstanding thesis that amazing products can deliver amazing results, even with some of our most intractable and challenging problems. We’re confident that Hello Heart is on a path toward improving the health and lives of millions of Americans, and we’re proud to back this amazing mission-driven, product-oriented team.” – Ron Shah, partner at Stripes.
